Your browser doesn't support javascript.
loading
5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Adl, Khaled; Sakr, Helmy; Nasser, Mohamed; Alswah, Mohamed; Shoman, Fatma M A.
Afiliação
  • El-Adl K; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
  • Sakr H; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, Egypt.
  • Nasser M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
  • Alswah M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
  • Shoman FMA; Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
Arch Pharm (Weinheim) ; 353(9): e2000079, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32515896

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Tiazolidinedionas / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Tiazolidinedionas / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito